Effective August 2, 2022, mdxhealth has acquired the Oncotype DX GPS (Genomic Prostate Score) test from Exact Sciences. To help ensure a smooth transition for patients, continue to place orders for this test through the existing Exact Sciences portal until further notice. Additionally, Genomic Health Inc, part of Exact Sciences, will continue to perform the Oncotype DX GPS test during the transition. Further communications explaining transition plans will be provided in the coming months. For more details, please review the following press release. Questions? Email: gps@mdxhealth.com

Jeff Elliott


Joined Exact Sciences: 2016

Jeff Elliott has served as our Executive Vice President and Chief Operating Officer since April 2021, and our Chief Financial Officer since November 2016. He previously served as Vice President, Business Development and Strategy, from June 2016 to November 2016. Prior to joining Exact Sciences, Mr. Elliott was with Robert W. Baird & Co., where from June 2012 to June 2016 he was a Senior Research Analyst who covered diagnostics and life science tools companies. Earlier in his career, Mr. Elliott worked in a supply chain role for Walgreens and as a consultant at Cap Gemini Ernst & Young. Mr. Elliott holds a Bachelor of Business Administration from the University of Illinois at Urbana-Champaign and a Master of Business Administration from the University of Chicago Booth School of Business. Mr. Elliott is a CFA charterholder.